Skip to content
SYK·NYSE·US

Stryker

Stryker is a global leader in medical technologies offering products and services in MedSurg, Neurotechnology and Orthopaedics. Its products are sold in approximately 61 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, and most are marketed directly to doctors, hospitals and other healthcare facilities.

Source: SEC 10-K Feb 11, 2026

Recent Activity

Updated Oct 17, 2026
–Stryker announced the appointment of insider Spencer Stiles as its new CEO, effective January 1, 2027, succeeding long-serving CEO Kevin Lobo.
–Stryker and CMR Surgical announced a strategic alliance to advance robotic-assisted surgery.

Past updates are part of the Pro plan.

Thematic Position

SYK

Relationship Groups

Suppliers1
Partners1
Licensing1
Competitors8

Relationship details are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

import restrictionsanctionlicensing requirement
Russian FSB import notifications and licenses required for importing Stryker products into Russia
SEC 10-KFeb 12, 2025

The full regulatory passage is part of the Pro plan.

1 more · Regulatory and geopolitical insights are part of the Pro plan.